Sfoglia per RIVISTA
THE LANCET. ONCOLOGY
Collezione AOU Alessandria

  

Items : 6

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. in The Lancet. Oncology / Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.

2022
AOU Alessandria
AOU Novara

Cortellini A; Gennari A; Tabernero J; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Grisanti S; Libertini M; Prat A; Tucci M; Rimassa L; Aujayeb A; Grosso F; Parisi A; Queirolo P; Mazzoni F; Caliman E; Santoro A; Giusti R; Zambelli A; Cantini L; Martinez-Vila C; Patriarca A; Gaidano G; Ruiz-Camps I; Bruna R; Fox L; et alii...

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6.

2021
AOU Alessandria

Maconi A; Bonelli C; Zanelli F; Perrino M; Santoro A; Gianoncelli L; Bonomi M; Pedrazzoli P; de Marinis F; Cappuzzo F; Soto Parra H; Grossi F; Tiseo M; Garassino MC; Pasello G; Grosso F; Pagano M; Zucali PA; Pinto C; Frega S; Gervasi E; Boni L; Ceresoli GL;

Adjuvant denosumab in early breast-cancer. in The Lancet. Oncology / Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8.

2020
ASL Alessandria
AOU Alessandria

Campisi G; Bedogni A; Fusco V;

Tumour Treating Fields for mesothelioma - Authors' reply. in The Lancet. Oncology / Lancet Oncol. 2020 Jan;21(1):e10. doi: 10.1016/S1470-2045(19)30831-9.

2020
AOU Alessandria

Ceresoli GL; Gianoncelli L; Grosso F;

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Dec;20(12):1702-1709. doi: 10.1016/S1470-2045(19)30532-7. Epub 2019 Oct 15.

2019
AOU Alessandria

Ceresoli GL; Aerts JG; Dziadziuszko R; Ramlau R; Cedres S; van Meerbeeck JP; Mencoboni M; Planchard D; Chella A; Crinò L; Krzakowski M; Rüssel J; Maconi A; Gianoncelli L; Grosso F;

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2015 Nov;16(15):1525-1536. doi: 10.1016/S1470-2045(15)00200-4. Epub 2015 Sep 28.

2015
AO Cuneo
AOU Alessandria

Bosi A; Bacigalupo A; Oldani E; Marfisi RM; Mordini N; Scimè R; Torelli GF; Corradini P; Alessandrino EP; Russo D; Nagler A; Marotta G; Carella AM; Arcese W; Terruzzi E; Saporiti G; Pini M; Risitano AM; Patriarca F; Guidi S; Pastore D; Chiusolo P; Raimondi R; Montanari M; Milone G; Santarone S; Cavattoni I; Busca A; Bruno B; et alii...